These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 19065751)
1. Initial management of epilepsy. Ammar H; Malani A; Mughal S N Engl J Med; 2008 Dec; 359(23):2500; author reply 2500. PubMed ID: 19065751 [No Abstract] [Full Text] [Related]
2. The place of levetiracetam in the treatment of epilepsy. Leppik IE Epilepsia; 2001; 42 Suppl 4():44-5. PubMed ID: 11564126 [No Abstract] [Full Text] [Related]
3. Issues in the treatment of epilepsy. Leppik IE Epilepsia; 2001; 42 Suppl 4():1-6. PubMed ID: 11564117 [No Abstract] [Full Text] [Related]
4. Spritam--a new formulation of levetiracetam for epilepsy. Med Lett Drugs Ther; 2016 Jun; 58(1497):78-9. PubMed ID: 27305068 [No Abstract] [Full Text] [Related]
5. An Unusual Side Effect Of A Commonly Used Antiepileptic Drug. Redkar N; Rawat KJ; Shah JH; Jena AB; Agrawal V J Assoc Physicians India; 2016 Feb; 64(2):98. PubMed ID: 27730799 [No Abstract] [Full Text] [Related]
7. A case of physical and mental adverse drug reactions associated with levetiracetam in post-stroke epilepsy. Robins A; Patel M; Azim A J Am Geriatr Soc; 2012 Jan; 60(1):159-60. PubMed ID: 22239298 [No Abstract] [Full Text] [Related]
8. Three new drugs for epilepsy: levetiracetam, oxcarbazepine, and zonisamide. Leppik IE J Child Neurol; 2002 Jan; 17 Suppl 1():S53-7. PubMed ID: 11918464 [TBL] [Abstract][Full Text] [Related]
9. Two new drugs for epilepsy. Med Lett Drugs Ther; 2000 Apr; 42(1076):33-5. PubMed ID: 10803174 [No Abstract] [Full Text] [Related]
10. The SKATE study: interim analysis. Olwen GO Int J Clin Pract; 2003; 57(6):544-5. PubMed ID: 12918896 [TBL] [Abstract][Full Text] [Related]
11. Role of levetiracetam in the treatment of epilepsy. Brodie MJ; French JA Epileptic Disord; 2003 May; 5 Suppl 1():S65-72. PubMed ID: 12915344 [TBL] [Abstract][Full Text] [Related]
12. [Keppra in epilepsy treatment: efficacy and tolerability]. Mukhin KIu; Pilin SV; Chadaev VA; Mironov MB; Petrukhin AS Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):49-51. PubMed ID: 15704484 [No Abstract] [Full Text] [Related]
13. Levetiracetam in pediatrics. Vigevano F J Child Neurol; 2005 Feb; 20(2):87-93. PubMed ID: 15794171 [TBL] [Abstract][Full Text] [Related]
14. Hypersomnia in an epilepsy patient treated with levetiracetam. Khatami R; Siegel AM; Bassetti CL Epilepsia; 2005 Apr; 46(4):588-9. PubMed ID: 15816957 [TBL] [Abstract][Full Text] [Related]
16. Meeting the challenge of treating epilepsy. Chadwick D; Wolf P Epileptic Disord; 2003 May; 5 Suppl 1():S7-8. PubMed ID: 12915335 [No Abstract] [Full Text] [Related]
17. Can High-Dose Levetiracetam Be Safe? A Case Report of Prolonged Accidental High-Dose Levetiracetam Administration and Review of the Literature. Kartal A Clin Neuropharmacol; 2017; 40(5):217-218. PubMed ID: 28682928 [TBL] [Abstract][Full Text] [Related]
18. Suicidal ideation in epilepsy and levetiracetam therapy. Mula M; Sander JW Epilepsy Behav; 2007 Aug; 11(1):130-2. PubMed ID: 17544331 [TBL] [Abstract][Full Text] [Related]
19. Clinical trials performed for the new drug approval process in the United States: standard methods and alternative methods. Browne TR Epilepsy Res Suppl; 1993; 10():31-44. PubMed ID: 8251105 [No Abstract] [Full Text] [Related]
20. Efficacy and tolerability of levetiracetam treatment in an epileptic patient with SLE. Siniscalchi A; Mancuso F; Gallelli L; Ferreri GI; Giovambattista DS Ann Pharmacother; 2005; 39(7-8):1367. PubMed ID: 15956229 [No Abstract] [Full Text] [Related] [Next] [New Search]